|
|
Found results for
 patents
1.
|
TOXOPLASMA PLATFORM FOR TREATING CANCER
| Application Number |
17614771 |
| Status |
Pending |
| Filing Date |
2020-05-29 |
| First Publication Date |
2022-07-28 |
| Owner |
- UNIVERSITÉ DE TOURS (France)
- KYMERIS THERAPEUTICS INC. (Canada)
- INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L' ALIMENTATION ET L'ENVIRONNEMENT (France)
|
| Inventor |
- Dimier-Poisson, Isabelle
- Mevelec, Marie-Noëlle
- Di Tommaso, Anne
- Aubrey, Nicolas
- Lantier, Louis
- Lee, Gordon
|
Abstract
A strain of an Apicomplexa of the family Sarcocystidae, wherein the strain is replicative and expresses one or more heterologous protein(s) selected from the group including therapeutic proteins, antigens, recombinant surface receptor or combinations thereof, and wherein the strain is selected from the group including Toxoplasma gondii and Neospora caninium. Also, the use of the strain for preventing or treating cancers or infectious diseases in a subject in need thereof.
IPC Classes ?
- A61K 35/68 - Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
- C07K 14/54 - Interleukins [IL]
- C07K 14/715 - ReceptorsCell surface antigensCell surface determinants for cytokinesReceptorsCell surface antigensCell surface determinants for lymphokinesReceptorsCell surface antigensCell surface determinants for interferons
- C07K 14/77 - Ovalbumin
- C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
|
2.
|
TOXOPLASMA PLATFORM FOR TREATING CANCER
| Application Number |
EP2020065086 |
| Publication Number |
2020/240024 |
| Status |
In Force |
| Filing Date |
2020-05-29 |
| Publication Date |
2020-12-03 |
| Owner |
- UNIVERSITÉ DE TOURS (France)
- KYMERIS THERAPEUTICS INC. (Canada)
- INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L' ALIMENTATION ET L'ENVIRONNEMENT (France)
|
| Inventor |
- Dimier-Poisson, Isabelle
- Mevelec, Marie-Noëlle
- Di Tommaso, Anne
- Aubrey, Nicolas
- Lantier, Louis
- Lee, Gordon
|
Abstract
Toxoplasma gondiiNeospora caniniumNeospora caninium. The present invention further relates to the use of said strain for preventing or treating cancers or infectious diseases in a subject in need thereof.
IPC Classes ?
- A61K 35/68 - Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
- C12N 15/79 - Vectors or expression systems specially adapted for eukaryotic hosts
- A61P 35/00 - Antineoplastic agents
- A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
- A61K 38/20 - Interleukins
- C07K 14/54 - Interleukins [IL]
- C07K 14/715 - ReceptorsCell surface antigensCell surface determinants for cytokinesReceptorsCell surface antigensCell surface determinants for lymphokinesReceptorsCell surface antigensCell surface determinants for interferons
- C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
|
3.
|
NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
| Application Number |
EP2018065179 |
| Publication Number |
2018/224656 |
| Status |
In Force |
| Filing Date |
2018-06-08 |
| Publication Date |
2018-12-13 |
| Owner |
- UNIVERSITÉ FRANÇOIS-RABELAIS DE TOURS (France)
- KYMERIS THERAPEUTICS INC. (Canada)
|
| Inventor |
- Dimier-Poisson, Isabelle
- Mevelec, Marie-Noëlle
- Ducournau, Céline
- Moire, Nathalie
- Mccrae, Richard
|
Abstract
The present invention relates to a strain of Neospora caninum for use in treating cancer or infectious diseases.
IPC Classes ?
- A61K 35/68 - Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
- A61P 31/06 - Antibacterial agents for tuberculosis
- A61P 31/18 - Antivirals for RNA viruses for HIV
- A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 35/00 - Antineoplastic agents
|
|
